4/A: Emergent BioSolutions Executive Corrects Stock Ownership in Amended SEC Filing

William Hartzel, SVP of Bioservices at Emergent BioSolutions, files an amended Form 4 to correct a clerical error in the previously reported amount of securities beneficially owned following a transaction involving restricted stock units.

Summary

• William Hartzel, SVP of Bioservices at Emergent BioSolutions Inc., filed an amended Form 4/A with the SEC.
• The filing corrects a clerical error in the previously reported amount of securities beneficially owned following a transaction on March 6, 2025.
• The original Form 4 incorrectly reported 109,975 shares, while the corrected filing shows 109,683 shares beneficially owned.
• The transaction involved the acquisition of 62,500 restricted stock units granted under the company's Stock Incentive Plan.
• These restricted stock units vest in three annual installments, beginning the day prior to the anniversary of the grant date, contingent upon continued service with the company.
• Each restricted stock unit represents the right to receive one share of Emergent BioSolutions Inc. common stock, subject to adjustments as per the grant agreement.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a clerical error. It doesn't contain any information that would significantly impact investor sentiment positively or negatively. The correction of the error is a positive sign of diligence.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the holdings of key personnel and aligns with regulatory requirements.

Stakeholder Impact

• The correction of the clerical error ensures accurate information for shareholders regarding executive stock ownership.

Key Dates

Keywords

Emergent BioSolutions, SEC Form 4/A, Beneficial Ownership, Restricted Stock Units, William Hartzel, Amendment, EBS